[{"NetIncomeLoss_2_Q2_USD":-27948000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":69604726.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-48099000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":20970000.0,"Depreciation_2_Q2_USD":1001000.0,"Depreciation_1_Q2_USD":501000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":5045000.0,"PaymentsToAcquireInvestments_2_Q2_USD":25912000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":5813000.0,"AssetsCurrent_0_Q2_USD":85536000.0,"RestructuringCharges_2_Q2_USD":64000.0,"RestructuringCharges_1_Q2_USD":7000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":31300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":-86000.0,"CommonStockSharesIssued_0_Q2_shares":71256579.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":36500000.0,"Assets_0_Q2_USD":97625000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-122000.0,"ShareBasedCompensation_2_Q2_USD":3042000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2575000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":17360000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2_Q2_USD":130000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q2_USD":122000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":68656566.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3566000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":7119000.0,"PreferredStockSharesOutstanding_0_Q2_shares":1164000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":20881000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10465000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-56000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1108000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":916066000.0,"Revenues_2_Q2_USD":3005000.0,"Revenues_1_Q2_USD":1514000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-1398000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1001000.0,"PreferredStockAccretionOfRedemptionDiscount_1_Q2_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-65000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":-56000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":17440000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":228000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-33921000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-17082000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-27818000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-13965000.0,"OtherAssetsNoncurrent_0_Q2_USD":173000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":45899000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2867000.0,"Liabilities_0_Q2_USD":32114000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-47000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-33000.0,"OperatingIncomeLoss_2_Q2_USD":-26288000.0,"OperatingIncomeLoss_1_Q2_USD":-13141000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q2_USD":2995000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6643000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-27948000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-14087000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1597000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24254000.0,"LiabilitiesCurrent_0_Q2_USD":6327000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1660000.0,"PreferredStockDividendsAndOtherAdjustments_2_Q2_USD":5973000.0,"NonoperatingIncomeExpense_1_Q2_USD":-946000.0,"InterestExpense_1_Q2_USD":1099000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":45899000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2040000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":80000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":6000.0,"PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_0_Q2_USD":143258000.0,"AdditionalPaidInCapital_0_Q2_USD":58300000.0,"PreferredStockSharesIssued_0_Q2_shares":1164000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":3181000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7741000.0,"NetIncomeLoss_1_Q2_USD":-14087000.0,"InterestExpense_2_Q2_USD":2140000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":304000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":0.0,"DividendsPreferredStockCash_2_Q2_USD":5973000.0,"AccountsPayableTradeCurrent_0_Q2_USD":1182000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":36489000.0,"RestructuringReserve_0_Q2_USD":0.0,"InvestmentIncomeInterest_2_Q2_USD":545000.0,"InvestmentIncomeInterest_1_Q2_USD":200000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":97625000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3042000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1597000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":364000.0,"OperatingExpenses_2_Q2_USD":29293000.0,"OperatingExpenses_1_Q2_USD":14655000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.49,"StockholdersEquity_0_Q2_USD":65511000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":66000.0,"ProceedsFromSaleOfRestrictedInvestments_2_Q2_USD":46948000.0,"LossContingencyEstimateOfPossibleLoss_0_Q2_USD":400000.0,"LongTermInvestments_0_Q2_USD":1600000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-40000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-151000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1004014000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":14100000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-96000.0,"CommonStockSharesOutstanding_0_Q2_shares":71256579.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.25,"GainLossOnSaleOfEquityInvestments_2_Q2_USD":0.0,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]